Hero Background Image
S
Small-Cap Growth

Baron Discovery Fund

Symbol BDFFXCUSIP: 068278860
Symbol BDFFXCUSIP: 068278860

Nav

$36.07

Daily Change $0.96 (2.73%)
As of 11/06/2026

Net Assets

$1.68 B

As of 09/30/2026

Morningstar Rating™*

As of 09/30/2026

Morningstar Medalist Rating™†

medal Logo

BRONZE

Inception date

09/30/2013

Prices & Performance

PricesAs of 11/06/2026

NAVDaily Change ($)Daily Change (%)MTDQTDYTD
$36.07$0.962.73%-1.96%1.23%3.03%
NAV$36.07
Daily Change ($)$0.96
Daily Change (%)2.73%
MTD-1.96%
QTD1.23%
YTD3.03%

PerformanceAs of 09/30/2026

Portfolio or IndexQTD1YTD11 Year3 Years5 Years10 YearsSince Inception 09/30/2013
BDFFX - Baron Discovery Fund-4.19%1.77%1.89%13.64%0.01%11.91%11.73%
Russell 2000 Growth Index-9.39%10.71%12.05%17.55%4.72%9.90%9.12%
Russell 3000 Index1.40%12.42%15.13%22.26%12.64%14.73%13.72%

Performance InformationAs of 09/30/2026

Performance statistics3 Years5 Years10 Years
Standard Deviation (%)21.2022.9922.88
Sharpe Ratio0.42-0.170.41
Alpha (%)-1.35-4.022.31
Beta0.890.960.99
R-Squared (%)78.5584.9586.07
Tracking Error (%)10.098.968.54
Information Ratio-0.39-0.530.24
Upside Capture (%)83.0486.70102.00
Downside Capture (%)86.88101.1695.25
Except for Standard Deviation and Sharpe Ratio, the performance based-characteristics above were calculated relative to the Baron Discovery Fund's(BDFFX) benchmark Russell 2000 Growth Index. Performance statistics for additional periods will be provided on request. Source FactSet: SPAR.

Risk & Return12/31/2015 - 12/31/2025

1 Source: FactSet SPAR.

Portfolio Holdings & Characteristics

HoldingsAs of 10/31/2026

HoldingSector% of Net Assets
Dynatrace, Inc.
Dynatrace, Inc. (DT) is a leading cloud-native observability and application security platform, providing full-stack monitoring, artificial intelligence–powered analytics, and automated problem resolution to help enterprises manage the performance of complex hybrid and multicloud environments.
Dynatrace, Inc. (DT), with its new platform, is better equipped to address complex use cases across multi-cloud, containerized, and hybrid environments. Estimates suggest only about 20% of enterprise applications are currently monitored, a figure expected to rise to 50% in the coming years. The growing application economy should drive greater monitoring demand as existing apps expand and new ones emerge. It is well positioned to capture this opportunity through its differentiated platform, enterprise-grade solutions, expanding salesforce, and ongoing product innovation.
Information Technology3.9%
Samsara Inc.
Samsara Inc. (IOT) is a leading connected operations platform providing fleet management, video safety, equipment monitoring, and site visibility solutions to industrial, transportation, and logistics customers across North America and Europe.
Samsara Inc. (IOT) has been rapidly gaining market share in the $51 billion connected fleet software market, driven by its superior cloud-native architecture, ability to address both safety and telematics use cases, and its proprietary data moat (over 20 trillion data points collected annually across more than 1 million assets). The company has leveraged its strong position in commercial fleets to expand into adjacent areas such as construction equipment monitoring and driver workflow automation, increasing its value to customers.
Information Technology3.2%
Loar Holdings Inc.
Loar Holdings Inc. (LOAR) is a fast-growing diversified manufacturer of proprietary aerospace and defense components, supplying highly engineered, sole-source parts for commercial aviation aftermarket, original equipment, and defense platforms, with a proven acquisition-driven growth model.
Loar Holdings Inc. (LOAR) has proprietary, aftermarket-focused products that represent one of the strongest business models in the aerospace and defense industry, exemplified by the success of peers such as TransDigm. Loar benefits from favorable industry growth trends and strong pricing power given the critical nature of its components. The company has executed a disciplined acquisition strategy, successfully integrating more than 17 acquisitions over the past 13 years. We believe Loar is well positioned to deliver strong double-digit growth for the foreseeable future.
Industrials3.0%
Repligen Corporation
Repligen Corporation (RGEN) is a leading bioprocessing technologies company, supplying filtration, chromatography, proteins, and analytics products used in the manufacture of biologics including monoclonal antibodies, gene therapies, and cell therapies for biopharmaceutical customers globally.
Repligen Corporation (RGEN) operates in attractive end markets, historically targeting monoclonal antibodies (8% to 10% market growth) and moving into cell and gene therapies (over 30% market growth). Because drug production is highly regulated, bioprocessing suppliers are embedded into workflows and their products have high stickiness. We also believe Repligen is one of the select life science tools companies able to leverage AI. Biologic drug production is still quite manual today, and Repligen is leading the charge on incorporating systems with real-time data collection.
Health Care2.9%
Liberty Live Holdings, Inc.
Liberty Live Holdings, Inc. (LLIVE) is a media holding company whose primary asset is a majority stake in Live Nation Entertainment, the world's largest live entertainment company, operating concert venues, ticketing through Ticketmaster, and artist management globally.
Liberty Live Holdings, Inc. (LLIVE) has an ownership stake in Live Nation, the dominant player in an industry with solid long-term demand trends. The company has significant opportunities for capital reinvestment. Its investment in new owned and operated venues drives higher concert segment margins versus third-party venues, largely due to Live Nation’s control of the profitable food and beverage business. As its mix shift to owned venues increases, we believe the resulting margin improvement will produce low double-digit growth in adjusted operating income over time.
Communication Services2.9%
CareDx, Inc.
CareDx, Inc. (CDNA) is the leading provider of transplant diagnostics and digital health solutions, offering genomic surveillance testing for heart, kidney, and lung transplant recipients to detect rejection, alongside software tools and laboratory products for transplant centers.
CareDx, Inc. (CDNA) is the leader in transplant diagnostics, with a presence in nearly all U.S. and EU centers. Its current growth is driven by AlloSure Kidney, which tests for signs of transplant rejection, and an increasing number of centers that are adopting surveillance protocols. Overall, CareDx addresses a $7 billion market and has the potential to reach $12 billion with new products.
Health Care2.8%
Netskope, Inc.
Netskope, Inc. (NTSK) is a leading cloud-native secure access service edge (SASE) provider. Its Netskope One platform runs on a privately owned global network and unifies web, cloud, data, and AI security with zero-trust access and SD-WAN, protecting how large enterprises’ users, apps, and AI agents connect.
Netskope, Inc. (NTSK) is a founder-led, next-generation share gainer in SASE, a market expected to double to over $30 billion by 2029 as enterprises replace firewalls and VPNs and adopt AI. Its owned network and ability to inspect cloud and AI traffic at the data layer drive technical win rates over 80% and gross retention over 96%, while cross-selling from over 25 modules sustains mid-teens net expansion. We believe agentic AI will multiply its network traffic, and that as growth investments and billing headwinds lap, margins can expand toward peers’ FCF levels over 25%.
Information Technology2.6%
Guidewire Software, Inc.
Guidewire Software, Inc. (GWRE) is the leading cloud-native software platform for the property and casualty insurance industry, providing core systems for policy, billing, and claims management to insurers globally, with accelerating cloud adoption among both regional and Tier 1 carriers.
Guidewire Software, Inc. (GWRE) is a best-in-class core system of record for P&C insurers, managing policies, claims, premiums, and payments across highly regulated workflows. We see a long runway as carriers modernize legacy systems, with the core opportunity approaching $20 billion of annual recurring revenue. AI should expand this opportunity through automation and intelligence layered on top of InsuranceSuite, while improving internal productivity. With the cloud migration largely complete, we expect accelerating revenue, margin expansion, and improving free cash flow.
Information Technology2.5%
Karman Holdings Inc.
Karman Holdings Inc. (KRMN) designs and manufactures proprietary, mission-critical systems for space and defense applications. Formed by Trive Capital from four legacy businesses, it holds significant sole- or single-source positions across hypersonics, missile defense, and space launch.
Karman Holdings Inc. (KRMN) has highly complex, mission-critical products and an ability to support customers from design through production that foster deep integration and long-term relationships. As a differentiated, full-lifecycle outsourced solutions partner to defense original equipment manufacturers, Karman is well positioned to benefit from rising investment in hypersonics, missile defense, and space launch.
Industrials2.4%
Rubrik, Inc.
Rubrik, Inc. (RBRK) is a leading cloud data security company offering a single platform for data protection, ransomware recovery, and data threat analytics across enterprise, cloud, and software-as-a-service environments, enabling organizations to secure and recover data at scale.
Rubrik, Inc. (RBRK) is a category leader rapidly taking share in an estimated $20 billion market via a superior security-first architecture, with win rates rising from 80% at IPO to over 90% in FY2026. Secular tailwinds from ransomware, data growth, and agentic AI expand the SAM, while new S-curves in identity resilience and Agent Rewind stack additional growth. Rubrik has tripled its market share in three years to roughly 7% of an approximately $20 billion market, displacing legacy vendors like Dell, IBM, and Veritas.
Information Technology2.4%
Total
28.6%
Top Ten Fund Holdings based on net assets. Portfolio holdings may change over time.
Portfolio holdings are subject to change. Current and future portfolio holdings are subject to risk.

Contributors / DetractorsQuarterly as of 09/30/2026

Top ContributorsAverage WeightContribution
CareDx, Inc.3.05%2.54%
Tempus AI, Inc.2.38%1.08%
Dynatrace, Inc.3.11%0.84%
Repligen Corporation2.51%0.82%
Heartflow, Inc.1.96%0.81%
Source: FactSet PA.

GICS Sector BreakdownAs of 10/31/2026

Sector

Industrials

26.2%

Information Technology

24.3%

Health Care

24.2%

Consumer Discretionary

10.6%

Communication Services

4.5%

Cash and Cash Equivalents

4.0%

Financials

4.0%

Consumer Staples

1.2%

Materials

0.9%

Life Sciences Tools & Services13.2%
Aerospace & Defense11.4%
Systems Software11.0%
Application Software7.4%
Restaurants5.5%
Movies & Entertainment4.5%
Industrial Machinery & Supplies & Components 4.0%
Environmental & Facilities Services3.6%
Pharmaceuticals3.6%
Health Care Equipment3.1%
Electronic Equipment & Instruments3.0%
Health Care Technology2.7%
Casinos & Gaming2.3%
Building Products2.1%
Trading Companies & Distributors2.0%
02468101214
Life Sciences Tools & Services13.2%
Aerospace & Defense11.4%
Systems Software11.0%
Application Software7.4%
Restaurants5.5%
Movies & Entertainment4.5%
Industrial Machinery & Supplies & Components 4.0%
Environmental & Facilities Services3.6%
Pharmaceuticals3.6%
Health Care Equipment3.1%
Electronic Equipment & Instruments3.0%
Health Care Technology2.7%
Casinos & Gaming2.3%
Building Products2.1%
Trading Companies & Distributors2.0%
02468101214

Portfolio CharacteristicsAs of 09/30/2026

DescriptionBaron Discovery FundRussell 2000 Growth Index
Inception DateSeptember 30, 2013
Net Assets$1.68 billion
# of Issuers / % of Net Assets62/99.6%
Turnover (3 Year Average)38.94%
Active Share96.2%
Median Market Cap$5.75 billion$1.38 billion
Weighted Average Market Cap$8.32 billion$4.41 billion
Expense Ratio1.33%
As of FYE Current Expense Ratio Date01/28/2026
EPS Growth (3-5 year forecast)20.5%15.3%
Price/Earnings Ratio (trailing 12-month)43.3x21.0x
Price/Book Ratio4.0x3.7x
Price/Sales Ratio4.0x1.6x
The Net Assets include all share classes combined.
Valuation metrics were calculated using a weighted harmonic average. Source: FactSet PA. Internal projections may differ.

Distributions

Record DateEx DatePayable DateIncomeReturn of CapitalShort-Term Capital GainLong-Term Capital GainTotalRe-Invest NAVCalendar-Year Return
11/22/202111/23/202111/24/2021$0.0000$0.0000$0.7794$0.5154$1.2948$35.104.63%
11/23/202011/24/202011/25/2020$0.0000$0.0000$0.0000$1.0614$1.0614$30.8365.71%
11/25/201911/26/201911/27/2019$0.0000$0.0000$0.0000$0.0286$0.0286$21.11
11/28/201811/29/201811/30/2018$0.0000$0.0000$0.0000$1.5004$1.5004$19.100.42%
11/27/201711/28/201711/29/2017$0.0066$0.0000$0.0000$0.0000$0.0066$18.1435.52%
For estimated distributions, visit the Tax Center